Luther King Capital Management (LKCM)
GILD icon

Luther King Capital Management (LKCM)’s Gilead Sciences GILD Stock Holding History

Luther King Capital Management (LKCM)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Buy
8,888
+531
+6% +$70K ﹤0.01% 410
2026
Q1 		$1.16M Buy
8,357
+356
+4% +$49.9K 0.01% 402
2025
Q4 		$982K Buy
8,001
+25
+0.3% +$3.04K ﹤0.01% 418
2025
Q3 		$885K Sell
7,976
-100
-1% -$11.4K ﹤0.01% 430
2025
Q2 		$895K Sell
8,076
-375
-4% -$39.9K ﹤0.01% 421
2025
Q1 		$947K Sell
8,451
-515
-6% -$53.1K ﹤0.01% 414
2024
Q4 		$828K Buy
8,966
+63
+0.7% +$5.67K ﹤0.01% 419
2024
Q3 		$746K Sell
8,903
-2,382
-21% -$182K ﹤0.01% 432
2024
Q2 		$774K Sell
11,285
-3,753
-25% -$250K ﹤0.01% 428
2024
Q1 		$1.1M Hold
15,038
– – 0.01% 391
2023
Q4 		$1.22M Sell
15,038
-733
-5% -$57K 0.01% 373
2023
Q3 		$1.18M Buy
15,771
+370
+2% +$28.5K 0.01% 373
2023
Q2 		$1.19M Buy
15,401
+96
+0.6% +$7.66K 0.01% 389
2023
Q1 		$1.27M Sell
15,305
-16
-0.1% -$1.32K 0.01% 359
2022
Q4 		$1.32M Sell
15,321
-44,836
-75% -$3.55M 0.01% 353
2022
Q3 		$3.71M Buy
60,157
+4,963
+9% +$313K 0.02% 211
2022
Q2 		$3.41M Buy
55,194
+32,210
+140% +$1.99M 0.02% 226
2022
Q1 		$1.37M Buy
22,984
+5,035
+28% +$322K 0.01% 357
2021
Q4 		$1.3M Sell
17,949
-541
-3% -$37.3K 0.01% 377
2021
Q3 		$1.29M Sell
18,490
-2,772
-13% -$195K 0.01% 374
2021
Q2 		$1.46M Buy
21,262
+11,857
+126% +$792K 0.01% 361
2021
Q1 		$608K Sell
9,405
-161
-2% -$10.4K ﹤0.01% 445
2020
Q4 		$557K Buy
9,566
+1,171
+14% +$70.7K ﹤0.01% 434
2020
Q3 		$530K Buy
8,395
+455
+6% +$31.6K ﹤0.01% 403
2020
Q2 		$611K Hold
7,940
– – ﹤0.01% 376
2020
Q1 		$594K Buy
7,940
+3,918
+97% +$271K 0.01% 366
2019
Q4 		$261K Sell
4,022
-7,473
-65% -$487K ﹤0.01% 501
2019
Q3 		$729K Buy
11,495
+2,314
+25% +$151K 0.01% 364
2019
Q2 		$620K Buy
9,181
+660
+8% +$43.4K ﹤0.01% 371
2019
Q1 		$554K Sell
8,521
-480
-5% -$31.9K ﹤0.01% 390
2018
Q4 		$563K Sell
9,001
-124
-1% -$8.67K 0.01% 390
2018
Q3 		$705K Buy
9,125
+1,000
+12% +$75.5K 0.01% 397
2018
Q2 		$576K Sell
8,125
-228
-3% -$16.1K ﹤0.01% 403
2018
Q1 		$630K Buy
8,353
+1,948
+30% +$155K 0.01% 398
2017
Q4 		$459K Hold
6,405
– – ﹤0.01% 426
2017
Q3 		$519K Sell
6,405
-200
-3% -$15.3K ﹤0.01% 403
2017
Q2 		$468K Sell
6,605
-1,946
-23% -$129K ﹤0.01% 398
2017
Q1 		$581K Sell
8,551
-11,029
-56% -$776K 0.01% 392
2016
Q4 		$1.4M Sell
19,580
-2,530
-11% -$188K 0.01% 315
2016
Q3 		$1.75M Sell
22,110
-1,700
-7% -$138K 0.02% 301
2016
Q2 		$1.99M Sell
23,810
-225
-0.9% -$20K 0.02% 292
2016
Q1 		$2.21M Sell
24,035
-880
-4% -$79.4K 0.02% 284
2015
Q4 		$2.52M Buy
24,915
+405
+2% +$42.1K 0.02% 288
2015
Q3 		$2.41M Sell
24,510
-288
-1% -$32K 0.02% 291
2015
Q2 		$2.9M Sell
24,798
-450
-2% -$49.2K 0.03% 286
2015
Q1 		$2.48M Sell
25,248
-214
-0.8% -$21.7K 0.02% 294
2014
Q4 		$2.4M Sell
25,462
-286
-1% -$29.6K 0.02% 299
2014
Q3 		$2.74M Sell
25,748
-1,006
-4% -$98.5K 0.02% 307
2014
Q2 		$2.22M Buy
26,754
+5,920
+28% +$461K 0.02% 313
2014
Q1 		$1.48M Buy
+20,834
New +$1.63M 0.01% 344

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Luther King Capital Management (LKCM)'s GILD Position: Q2 2026 in Review

Luther King Capital Management (LKCM) increased its Gilead Sciences (GILD) stake by 6.4% in Q2 2026, buying an estimated $70K and bringing the position to 8,888 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #410.

Luther King Capital Management (LKCM) first reported a position in GILD in Q1 2014 and has held it in 50 quarters since. The position peaked at $3.71M in Q3 2022. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Luther King Capital Management (LKCM) held 8,888 shares of Gilead Sciences worth $1.12M as of Q2 2026.
  • Luther King Capital Management (LKCM) bought 531 Gilead Sciences shares in Q2 2026, an estimated $70K.
  • Gilead Sciences made up ﹤0.01% of Luther King Capital Management (LKCM)'s portfolio in Q2 2026, its #410 holding.
  • Luther King Capital Management (LKCM) first reported a position in Gilead Sciences in Q1 2014 and has held it in 50 quarters since.
  • Luther King Capital Management (LKCM)'s Gilead Sciences position peaked at $3.71M in Q3 2022.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2026, filed 10 Aug 2026.